Edition:
United States

Opiant Pharmaceuticals Inc (OPNT.OQ)

OPNT.OQ on NASDAQ Stock Exchange Capital Market

23.50USD
14 Dec 2017
Change (% chg)

$-0.61 (-2.53%)
Prev Close
$24.11
Open
$24.10
Day's High
$24.50
Day's Low
$21.35
Volume
38,503
Avg. Vol
--
52-wk High
$51.90
52-wk Low
$21.35

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Michael Sinclair

73 2012 Executive Chairman of the Board

Roger Crystal

38 2009 President, Chief Executive Officer, Director

David O'Toole

58 2017 Chief Financial Officer

Arvind Agrawal

2015 Executive Vice President - Medical Affairs

Phil Skolnick

69 2017 Chief Scientific Officer